In-PharmaTechnologist
1,730 FOLLOWERS
In-PharmaTechnologist.com is a daily news service that provides news stories and data of value to decision-makers in the Pharmaceutical Technology industry.
In-PharmaTechnologist
4y ago
Following API constraints due to the coronavirus, the Indian government takes measures to bolster domestic capabilities ..read more
In-PharmaTechnologist
4y ago
In order to boost the supply of chloroquine, the US FDA has allowed Ipca to supply APIs and finished product to the country ..read more
In-PharmaTechnologist
4y ago
A rundown of the latest updates emerging from industry in response to the developing coronavirus pandemic ..read more
In-PharmaTechnologist
4y ago
Health Canada marked the first positive nod to ViiV for its once-monthly HIV regimen, following rejection by the US FDA ..read more
In-PharmaTechnologist
4y ago
Medivant to prioritize manufacturing of four generic drugs for cardiac diseases, amid fears of drug shortages due to COVID-19 ..read more
In-PharmaTechnologist
4y ago
The US FDA announces that it will no longer be able to carry out domestic facility inspections due to the risk posed by COVID-19 ..read more
In-PharmaTechnologist
4y ago
Biohavenâs drug for acute treatment of migraine, manufactured using Catalentâs Zydis technology for orally disintegrating tablets, receives approval from the US FDA ..read more
In-PharmaTechnologist
4y ago
Both the US FDA and EMA are updating timelines of steps taken to prevent the spread of the virus and to secure supply chains ..read more
In-PharmaTechnologist
4y ago
Windlas issued a warning letter by the US FDA after the regulator finds the manufacturerâs response inadequate to justify wrongdoings at its India facility ..read more
In-PharmaTechnologist
4y ago
Manufacturers of hydroxychloroquine are increasing production and a number have offered to donate doses to combat COVID-19 ..read more